The microbiota-gut-brain axis is a complex network that includes the enteric nervous system (ENS), the autonomic nervous system (ANS), and the neuroendocrine and neuroimmunity of the central nervous system (CNS). The microbiota-gut-brain axis can send signals through a multitude of channels. These processes have a variety of effects on physiological function. The gut-liver axis refers to the gastrointestinal tract and liver's intimate anatomical and functional link. The transfer of IM-associated molecules to the liver occurs during the interaction between the two organs, whether healthy or sick. The microbiota-gut-liver-brain axis controls the onset and progression of many diseases, and it provides a new avenue for disease study. There have been an increasing number of studies on the microbiota-gut-liver-brain axis in recent years, which has not only improved our understanding of its pathogenesis but also provided numerous new therapy options.
Title : Overcoming manufacturing challenges in next-generation probiotics: From anaerobic cultivation to clinical-grade formulation
Jason Ryan, Sacco System, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic – results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India
Title : A case-cohort study of the outcomes of probiotics on wound healing in a private hospital in Abu Dhabi
Najat Amharar, Burjeel, United Arab Emirates
Title : Potential for prebiotic food supplement production from by-products of dried persimmon (Diospyros kaki)
Yasin Ozdemir, Ataturk Horticultural Central Research Institute, Turkey